Pluto Biosciences, Inc

GSE77113: HDAC3 modulates enhancer activity to regulate terminal B cell differentiation

Bulk RNA sequencing

B220+GL7+ (GC) and B220+GL7- (non-GC) B cells were sorted from SRBC-immunized mice deficient for Hdac3 and wild type controls. RNA-sequencing revealed an upregulation of critical regulators of B cell differentiation in Hdac3-deleted animals. SOURCE: Scott Hiebert ( - Dr, Scott Hiebert Vanderbilt University

View this experiment on Pluto Biosciences, Inc